Journal of Oncology and Cancer Research

Biography

I have a broad background in the field of Cancer and Immunology, with specific training and expertise in cancer therapeutics and translational science pertaining to natural compounds and drug repurposing. My current research includes identifying novel functions of FDA approved compounds and their combinations in targeting endocrine cancers and assessing their mechanism of actions. I have worked elaborately in pancreatic ductal adenocarcinoma and have identified the potential interaction KDM3A with DCLK-1 and their role in PDAC tumorigenesis and stemness. In this work I also established that N-oxalylglycine (NOG), α-ketoglutarate mimetic affects KDM3A activity. In another project I focused on identifying the cluster of master transcription factors or Super-Enhancers as novel targets for Pancreatic Adenocarcinoma using Combination of natural Compounds as anticancer agents. My doctoral thesis was on identification and characterization of Toll-like Receptors (TLR-2, 4, 6) in thymic, splenic and lymph node lymphocytes and macrophages of Swiss albino mice and their role in S. aureus infection and lipopolysaccharide administration. In addition, I have successfully published my research works in good peer-reviewed journals.

Research Interest

Cancer research, Immunology